Saturday, September 12, 2026

Home
News
Gender
Investigations
SPECIAL REPORT: Why young Nigerians are losing faith in elections

INVESTIGATION: Oil companies violate Nigerian laws, flare gas, face no sanctions (1)

INVESTIGATION: How criminals exploited Benue’s conflicts to traffic children, women

INVESTIGATION: The multi-million dollar Norwegian scam and the role of a Nigerian

SPECIAL REPORT: How social media shapes reprisal violence in Plateau

SPECIAL REPORT: Some Nigerians turn to faith healers as HIV aid dries up

SPECIAL REPORT: Before they could finish school, Nigeria’s health system made them mothers

Akwa Ibom governor abandons assembly rehabilitation but pushes N248.83bn tourism projects

SPECIAL REPORT: In Jigawa communities, nutrition programmes offer hope amid child hunger
Business
Opinion
Friday Sermon: Senator Shehu Buba Umar is now innocent, until proven guilty!, By Murtadha Gusau

When a black scholar becomes a symbol: The Jason Arday controversy, By Toyin Falola

The “Daily Times” we wish for, but can’t have, By Azu Ishiekwene

Mass weddings as social policy: What happens after the ceremony? (1), By Ismail Ahmed

Rufai Oseni and the burden of objectivity, By Niran Adedokun

AU and the struggle for transitional justice implementation in South Sudan, By John G. Ikubaje
Health
Agriculture
Arts/Life
- Arts/Books
- Kannywood
- Lifestyle
- Music
- Nollywood
- Travel
Sports
Elections

Tag: Incepta

L-R: Business Lead, VIYA Health, Billy Shoaga; Technical Support Unit Coordinator for Reproductive, Maternal, Newborn, Child, Adolescent, and Elderly Health (RMNCAEH) Selfcare Project, Federal Ministry of Health and Social Welfare, Mr Lawrence Anyanwu; Representative of the Director, Family Health, Federal Ministry of Health and Social Welfare, Dr Samuel Oyeniyi; Assistant General Manager, International Marketing Strategy Department, Incepta Pharmaceuticals, Arifur Rahman; and Program Analyst, AIMS Project, Solina Centre for International Development & Research (SCIDaR), Dr Utibe Antaih, during a stakeholder engagement session on DMPA SC Access of a WHO PreQualified (WHO PQ) DMPA SC (Self Inject) - Medogen SubQ and Meuri-SubQ, which held at the Federal Ministry of Health and Social Welfare with Incepta Pharmaceuticals and VIYA Health (Incepta's Sole Representative for Medogen SubQ and Meuri-SubQ in Nigeria), recently.

Health Ministry engages VIYA Health and Incepta to expand access to WHO-prequalified solution

byPress Release

VIYA Health takes lead as exclusive distributor of Incepta’sWHO-prequalified DMPA-SC (self-inject) in Nigeria

Prev Next

DMCA.com Protection Status

All content is Copyrighted © 2025 The Premium Times, Nigeria